NEW CASTLE, Del., May 22, 2013 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, announces that the Company is in expansion funding negotiations with a Hong Kong investment banking syndicate. Funding commitments will enable the Company to aggressively pursue acquisition and joint venture opportunities in the U.S. and Asia.
Bob Schneiderman, CEO of ScripsAmerica, said, "We are very excited to announce our funding negotiations and the incredible potential for ScripsAmerica. The funding will not only allow the Company to pursue acquisition opportunities, but additionally will provide the capital to aggressively launch our RapiMed® product line."
Schneiderman concluded, "ScripsAmerica is a fundamentally strong Company with a truly innovative product in RapiMed®. In our opinion, expansion funding will take us to the next level of growth. We firmly believe 2013 will be a breakout year for ScripsAmerica and its shareholders."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry through the largest pharmaceutical distributor in North America, McKesson Corporation. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, CutisPharma, Inc., and the United States Veterans Administration and Department of Defense.
RapiMed(R) is created for children who have difficulties swallowing medication, and for parents who are tired of measuring cups and syringes. RapiMed(R) products are easy to administer since they are rapid dissolving, precise dosage, individually wrapped child proof packages, and easy to carry around wherever you go. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: 888-959-7095Source:ScripsAmerica, Inc.